Diabetes Devices Market Growth, Future Prospects and Competitive Analysis, 2016-2022, the global diabetes devices market was valued at USD 20.4 Bn in 2015, and is expected to reach USD 28.2 Bn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022.
Browse Full Report Visit – http://www.acutemarketreports.com/report/diabetes-devices-and-drugs-market
With approximately 385 Mn diabetic patients and a burden of 175 Mn undiagnosed population, the burden of diabetes is significant. Lifestyle, increase in obesity prevalence, dietary changes and ageing are some of the critical factors contributing to the growing prevalence of diabetes worldwide. The global diabetes management market is majorly driven by rising disease prevalence, technological innovation, growing preference for automated disease management solutions are the prime drivers of diabetes devices market.
Growth of the global diabetes management devices market is also supported by significant investments, scope of penetration in middle- and low-income countries and increasing awareness in patient population about effective diabetes management and thereby prevention of disease related complications. On the other hand, high costs of novel diabetes management products and monitors, compliance issues, safety concerns and reimbursement issues are some of the market hindrances faced by the diabetes device manufacturers.
This report classifies the overall diabetes devices market into insulin delivery devices and glucose monitoring devices segments. The insulin delivery devices segment studies individual market for insulin pumps, insulin syringes, insulin pens and insulin inhalers. The glucose monitoring products studied in this report include test strips, lancing devices and lancets, glucose meters and continuous glucose monitors. Insulin delivery devices currently take the larger share of the overall diabetes devices market and it is anticipated that the demand for these products shall remain high through the forecast period. Additionally, continuous glucose monitors is anticipated to be the fastest growing segment in the total market, where the growth is facilitated by rapid technological innovation in this field by players such as Dexcom and prove efficiency of these devices in management of both type 1 and type 2 diabetes.
Geographically, North America and Europe are the largest regional markets for diabetes devices. High awareness, diabetes prevalence and evolved reimburse systems for novel drug delivery and monitoring systems are the prime market growth drivers in these regions. Furthermore, Asia-Pacific and Middle East and Africa are the fastest growing regions in the global market. Phenomenal rise in diabetes prevalence in countries such as India, China and Middle East countries are the major growth facilitators in these region.
The overall diabetes devices market is led by F. Hoffmann La Roche through its flagship product line Accu Chek and is followed by Animas Corporation and LifeScan with their wide product offering. Eli Lilly currently is among the top players in the diabetes delivery devices segment.
Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-devices-market
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Insulin Delivery Devices Market Share, 2015 & 2022 (Value %)
2.2 Glucose Monitoring Devices Market, 2015 (USD Mn)
2.3 Diabetes Devices Market Share, by Geography, 2015 (Value %)
Chapter 3 Diabetes Devices Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players
Chapter 4 Global Insulin Delivery Devices Market Analysis, 2014-2022 (USD Mn)
4.2 Insulin Pumps
4.3 Insulin Syringes
4.4 Insulin Pens
4.5 Insulin Inhalers
Chapter 5 Global Glucose Monitoring Devices Market Analysis, 2014-2022 (USD Mn)
5.2 Glucose Test Strips
5.3 Lancing Devices and Lancets
5.4 Glucose Meters
5.5 Continuous Glucose Monitoring
Chapter 6 Global Diabetes Devices Market, by Geography, 2014-2022 (USD Mn)
6.2 North America
6.3.3 Rest of Europe
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America
To Get Complete Report @ http://www.acutemarketreports.com/report/diabetes-devices-and-drugs-market
Chapter 7 Company Profiles
7.1 Dexcom, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Johnson & Johnson (LifeScan, Inc. and Animas Corporation)
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Novo Nordisk
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Abbott Laboratories
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Roche Diagnostics
7.5.1 Business Description
Latest Reports :
Our Blog :- http://www.newzmarket.com/
About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : firstname.lastname@example.org
Website : http://www.acutemarketreports.com